Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer-Reference-Cited by-同舟云学术

Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer

Published:2017-07-12 Issue:8 Volume:141 Page:1600-1614
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Kritsch Daniel¹,Hoffmann Franziska¹,Steinbach Daniel¹,Jansen Lars¹,Mary Photini Stella²,Gajda Mieczyslaw³,Mosig Alexander S.⁴,Sonnemann Jürgen⁵,Peters Sven⁶,Melnikova Margarita⁷,Thomale Jürgen⁷,Dürst Matthias¹,Runnebaum Ingo B.¹,Häfner Norman¹^ORCID

Affiliation:

1. Department of Gynecology and Reproductive Medicine; Jena University Hospital, Friedrich-Schiller University; Jena Germany

2. Department of Obstetrics; Jena University Hospital, Friedrich-Schiller University; Jena Germany

3. Institute of Pathology, Jena University Hospital, Friedrich-Schiller University; Jena Germany

4. Department of Biochemistry II; Jena University Hospital, Friedrich-Schiller University; Jena Germany

5. Children's Clinic; Department of Pediatric Hematology and Oncology, Jena University Hospital, Friedrich-Schiller University; Jena Germany

6. Experimental Ophthalmology, Jena University Hospital, Friedrich-Schiller University; Jena Germany

7. DNA Repair Lab, Institute for Cell Biology, University Hospital Duisburg-Essen; Essen Germany

Funder

Deutsche Forschungsgemeinschaft

IZKF Jena

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.30860/fullpdf

Reference49 articles.

1. Rethinking ovarian cancer: recommendations for improving outcomes;Vaughan;Nat Rev Cancer,2011

2. New hypothesis on pathogenesis of ovarian cancer lead to future tailored approaches;Rescigno;Biomed Res Int,2013

3. Ovarian cancer: strategies for overcoming resistance to chemotherapy;Agarwal;Nat Rev Cancer,2003

4. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom;Du Bois;Cancer,2009

5. HE4: a new potential early biomarker for the recurrence of ovarian cancer;Anastasi;Tumour Biol,2010

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FDA-approved antivirals ledipasvir and daclatasvir downregulate the Src-EPHA2-Akt oncogenic pathway in colorectal and triple-negative breast cancer cells;Biomedicine & Pharmacotherapy;2024-10

2. Role of long non-coding RNA in chemoradiotherapy resistance of nasopharyngeal carcinoma;Frontiers in Oncology;2024-02-29

3. Tribbles Genes in Gastric Cancer: A Tumor-Suppressive Role for TRIB2;Genes;2023-12-23

4. The role of DNA methylation in ovarian cancer chemoresistance: A narrative review;Health Science Reports;2023-04-27

5. Synthesis, Characterization and Biological Investigation of the Platinum(IV) Tolfenamato Prodrug–Resolving Cisplatin-Resistance in Ovarian Carcinoma Cell Lines;International Journal of Molecular Sciences;2023-03-16